Bexicaserin (INNTooltip International Nonproprietary Name; developmental code names LP352 and AN352) is a selective serotonin 5-HT2C receptor agonist which is under development for the treatment of Dravet syndrome and Lennox–Gastaut syndrome. It is taken by mouth.
Bexicaserin (INNTooltip International Nonproprietary Name; developmental code names LP352 and AN352) is a selective serotonin 5-HT2C receptor agonist which is under development for the treatment of Dravet syndrome and Lennox–Gastaut syndrome. It is taken by mouth.
Source: Wikipedia "Bexicaserin" · CC BY-SA 4.0
Share this article: X · Bluesky